BUTALBITAL AND ACETAMINOPHEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butalbital And Acetaminophen, and what generic alternatives are available?
Butalbital And Acetaminophen is a drug marketed by Dr Reddys Labs Sa, Granules, Alvogen, Halsey, Larken Labs Inc, Lgm Pharma, Mikart, Ne Rx Pharma, Quagen, Senores Pharms, and Watson Labs. and is included in thirteen NDAs.
The generic ingredient in BUTALBITAL AND ACETAMINOPHEN is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUTALBITAL AND ACETAMINOPHEN?
- What are the global sales for BUTALBITAL AND ACETAMINOPHEN?
- What is Average Wholesale Price for BUTALBITAL AND ACETAMINOPHEN?
Summary for BUTALBITAL AND ACETAMINOPHEN
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 13 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 3 |
Patent Applications: | 2 |
DailyMed Link: | BUTALBITAL AND ACETAMINOPHEN at DailyMed |
Recent Clinical Trials for BUTALBITAL AND ACETAMINOPHEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
GlaxoSmithKline | Phase 3 |
Pharmacology for BUTALBITAL AND ACETAMINOPHEN
Drug Class | Barbiturate |